BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 10465061)

  • 1. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.
    He J; Whelton PK
    J Hypertens Suppl; 1999 Jun; 17(2):S7-13. PubMed ID: 10465061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials.
    He J; Whelton PK
    Am Heart J; 1999 Sep; 138(3 Pt 2):211-9. PubMed ID: 10467215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure and coronary heart disease: a review of the evidence.
    Lawes CM; Bennett DA; Lewington S; Rodgers A
    Semin Vasc Med; 2002 Nov; 2(4):355-68. PubMed ID: 16222626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
    J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High blood pressure and end-organ damage.
    Cutler JA
    J Hypertens Suppl; 1996 Dec; 14(6):S3-6. PubMed ID: 9023707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertension as a function of age].
    Gensini GF; Corradi F
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arterial hypertension and cardiovascular risk. Epidemiological studies, trials and therapeutic implications].
    Iannetti M; Vallebona A; Caponnetto S
    Minerva Cardioangiol; 1991 Oct; 39(10):367-74. PubMed ID: 1803282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive therapy in the elderly: results of large trials].
    Leonetti G; Cuspidi C; Facchini M
    Ital Heart J Suppl; 2001 Nov; 2(11):1161-9. PubMed ID: 11775407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure and end-stage renal disease in men.
    Klag MJ; Whelton PK; Randall BL; Neaton JD; Brancati FL; Ford CE; Shulman NB; Stamler J
    N Engl J Med; 1996 Jan; 334(1):13-8. PubMed ID: 7494564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systolic-diastolic arterial hypertension versus isolated systolic hypertension].
    Giannuzzi P; Eleuteri E
    Ital Heart J; 2000 Jun; 1 Suppl 2():93-9. PubMed ID: 10905135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension in the elderly].
    Plouin PF; Rossignol P; Bobrie G
    Bull Acad Natl Med; 2006; 190(4-5):793-805; discussion 806, 873-6. PubMed ID: 17195607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS).
    Mason PJ; Manson JE; Sesso HD; Albert CM; Chown MJ; Cook NR; Greenland P; Ridker PM; Glynn RJ
    Circulation; 2004 Apr; 109(13):1623-9. PubMed ID: 15023883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The paradigm has shifted to systolic blood pressure.
    Black HR
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S3-7. PubMed ID: 15592571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risks of hypertension: lessons from observational studies.
    O'Donnell CJ; Kannel WB
    J Hypertens Suppl; 1998 Oct; 16(6):S3-7. PubMed ID: 9856377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the implications for the community of the discrepancy between the theory and practice of BP control?
    Jackson R
    J Hum Hypertens; 1995 Jul; 9 Suppl 2():S25-8. PubMed ID: 7562894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?
    Leonetti G; Cuspidi C; Facchini M; Stramba-Badiale M
    J Hypertens Suppl; 2000 Jul; 18(3):S13-20. PubMed ID: 10952083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure lowering for the primary and secondary prevention of coronary and cerebrovascular disease.
    MacMahon S; Neal B; Rodgers A
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2479-86. PubMed ID: 8571098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.